News & Articles

Vascular Specialty Center Physician Co-authors Results of Leading Vascular Clinical Trial Results Zymo trial - J Am Coll Surg. 2007 Aug; 205(2):256-65.)

Baton Rouge, LA – A Vascular Specialty Center physician has recently co-authored results of a Phase 3 multiple site, randomized, double-blind, controlled trial designed to evaluate the comparative efficacy and safety of rhThrombin and bovine thrombin in patients undergoing spinal surgery, hepatic resection, peripheral arterial bypass surgery, or arteriovenous graft formation for hemodialysis access (Journal of the American College of Surgeons 2007 Aug; 205(2):256-65.).  Results of this trial suggest that rhThrombin has comparable efficacy, a similar safety profile, and is considerably less immunogenic than bovine thrombin when used for surgical hemostasis.

“As a principle investigator and leading enroller for the trial, our efforts in the execution of this trial were vital to the success of this important research”, says Wendy Frierberger, director of clinical research, Vascular Specialty Center.

About Vascular Specialty Center, PMC

Vascular Specialty Center in the largest single specialty vascular and endovascular surgical practice in Louisiana with headquarters in Baton Rouge, LA.  Its subsidiaries include Vascular Specialty Laboratory (VSL) and Total Vein Care of Louisiana TM  (TVC).  VSL serves as the largest vascular laboratory in the state and serves the entire Gulf Coast region performing more than 12,000 non-invasive studies yearly.  TVC is the leading freestanding gulf coast clinic dedicated to the complete medical, surgical and cosmetic care of problematic veins performing more minimally invasive, endoluminal vein ablations than any center in the Southeastern United States.   

www.brvsc.com
www.TotalVeinCareLouisiana.com